ENDOTEXT: Instructions for Authors

Thank you for participating in Endotext, an online resource providing information for physicians caring for Endocrine patients around the world. Our 450 authors are the very best clinician/teacher/researchers in the world, and our website is the “NY Times” of Endocrine websites.  Endotext is also the only Endocrine textbook indexed in PubMed. With your help, we will maintain these high standards.




Endotext is produced by the non-profit owning company, MDText.com, Inc. Our company was formed in Massachusetts and is a non-profit corporation directed by the section editors and authors. MDText.com, Inc. is run by Ashley Grossman, MD (President), George Chrousos, MD (Vice-President), Jon Purnell, MD (Treasurer) and Fred Singer, MD (Secretary).  The editor of Endotext is Kenneth Feingold. In case you are a new member of the Endotext team, All Section Editors are Directors and all Authors are Members of our non-profit corporation. The control of our company is the same as with any other corporation, with Directors electing officers at our annual meeting, and they in turn run the company on a day to day basis.

Our web textbook is directed to practicing physicians and trainees. This audience includes not only Endocrinologists but also a larger body of physicians seeing Endocrine patients who need ready access to well formulated and clear information on these diseases. Thus, we want to emphasize clinical material, especially disease course, diagnosis, and the latest information on therapy. Enough background on biochemistry, physiology, and pathophysiology should be included for completeness. To set the “level” is difficult. We are not preparing a primer, but rather a text directed to practicing endocrinologists and fellows, as well as general physicians and students. We should provide the same kind of clinically oriented material found in a multi-volume specialty text. We currently are, and intend to be, the equal to (or better than) any currently published hard-cover endocrine text. Perhaps we may visualize something quite distinct – in depth coverage of clinical endocrinology in a single site. We will not print, thus saving an enormous expense and we are able to put material on line and do revisions almost instantaneously.



  • Use doc or Word.docx
  • Use Arial font throughout
  • Title Page, include the following information in these formats:
  • Authors (BOLD, 12 point) All new authors must register as ENDOTEXT users in order to be listed as authors (registration is free).
  • Affiliations (Please give appropriate titles and affiliations, and e-mail addresses for all authors) 10 point
  • Abstract, as required for PubMed:
    • Please provide a 500 words or less overviewof your chapter
    • Text -11 point
  • Main Body, use the following formatting:
  • Sub-section Headings (H3) (Bold, Capitalize Each Word, 11point) (Heading 3)
  • Sub-Sub Section HEADINGS (H4) (Capitalize words,11pt) (Heading 4)
  • Sub-sub-sub section headings (H5) Italicize, 11 point
  • Text (11 point).
    • Separate paragraphs by a space. Do not indent.
    • Please insert reference numbers into the text in parentheses (1, 2) and list references at the end of the chapter numerically in order of appearance. Use any number of references you wish, but obviously it will be helpful to readers if you list primarily important and new sources, and you do not need to document every minor point. The style for references is that used in JCEM: Authors:Title:Journal or book citation. Please check that your bibliography is complete.

For EndNote users here is the file: http://endnote.com/downloads/style/journal-clinical-endocrinology-and-metabolism

  • We encourage you to cite other Endotext chapters whenever Endotext chapters are indexed on PubMed so they are easy to reference using reference managing systems such as EndNote, and their use builds our citation Index, which is important for visibility of our website..
  • Most importantly, pleaseindicate all important sections by new headings using important keywords if possible, since this will improve indexing, and make our site more useful.
  • Line Spacing- this should be 1.15. There should be a space between all new paragraphs


  • Tables and Figures:
  • We would like to have very liberal use of Tables and Figures since these can provide quick and effective data for practicing physicians who may not have time to read a large text. Please insert tables and figures directly in the text where appropriate. We recommend having an average of one figure for each 2-3,000 words.
  • Create Tables using the MS Word table function. Please list the Table title in the Table in bold type.
  • Liberal use of colored figures is strongly encouraged! Please insert figures directly in the text, and if possible, also provide separately in “JPEG”, GIF, or PNG format. Please do not include the figure title, number, or legend within the figure.
  • As usual, we will need written permission to re-use any figure published elsewhere. Since many journals charge for permission to re-use a figure, and we are unable to provide support for this expense, it is often preferable to modify an illustration so that it is not the same as the original, or to produce a new figure, rather than republishing a figure- for example from JCEM or NEJM. Often authors, if asked, will provide a new and different figure for your use and they can be given credit.



  • In an effort to convey the chronic nature of many of the diseases referred to in this textbook, where applicable, please refer to patients “with acromegaly,” “with diabetes,” “with hypertension,” or “who are obese,” rather than “acromegalics”, “diabetics,” “hypertensives,” or “obese patients.”
  • DOSAGES AND SPECIFIC TREATMENTS - Please check all references to dosages and specific treatments very carefully.
  • COPYRIGHT The copyright is owned by MDText.com,INC. For newly written chapters, the authors will transfer copyright to the chapters to MDText.com,INC.
  • Please be sure to add your Endotext publication to your own CV, and to cite it in your lectures and publications. As noted, chapters are indexed on PubMed and therefore are very easy to cite.



Revised chapters are expected every 36 months and you will receive notification (along with a Word.doc of your current chapter) that an update is due from your Section Editor at the beginning of the third year since your last submission.  In between revisions and at your discretion, we encourage updates whenever important changes related to your topic occur. Examples might include a scientific breakthrough in physiology or pathophysiology, availability of new medications / procedures, or changes in guidelines for disease management.  For minor changes or updates (typically a paragraph or less), you may send your selected revisions directly to your Section Editor for incorporation without redoing the entire chapter.

Follow the guidelines above for formatting and submitting revisions using. Track Changes function in Word

  • Be sure to update all authors, titles, and affiliations
  • Please mark all new material by using the Track Changes function in Word.


Send the Revision to your Section Editor, who will review it and forward it to the Editor. We will then replace the entire chapter online. We can also add/replace figures as you wish.

For further information or problems, please contact Kenneth Feingold MD, at kenneth.feingold@ucsf.edu  or 415-302-8463.